Joseph B Shrager, MD
Thoracic Surgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
- Since medical school
- 38 years
- Harvard Medical School, 1988
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shrager’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G88316 · Current
Licensed to practise in California · since 2008 · expires 2027-11-30 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Surgery - Surgery
- American Board of Thoracic Surgery - Thoracic and Cardiac Surgery
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$69,647
Medicare paid this office $69,647 for 215 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 70 | $10,882 | $120 |
| Initial removal of wedge of lung tissue using an endoscope | 11 | $7,847 | $713 |
| Return visit (30+ min) | 53 | $5,626 | $85 |
| New patient visit (60+ min) | 31 | $4,706 | $152 |
| New patient visit (60+ min) | 23 | $4,455 | $194 |
See all 9 services
| Return visit (30+ min) | 70 | $10,882 | $120 |
| Initial removal of wedge of lung tissue using an endoscope | 11 | $7,847 | $713 |
| Return visit (30+ min) | 53 | $5,626 | $85 |
| New patient visit (60+ min) | 31 | $4,706 | $152 |
| New patient visit (60+ min) | 23 | $4,455 | $194 |
| Removal of lymph nodes of chest cavity using an endoscope | 14 | $2,422 | $173 |
| Long return visit (40+ min) | 11 | $2,071 | $173 |
| Short return visit (20+ min) | 23 | $1,974 | $79 |
| Short return visit (20+ min) | 13 | $723 | $52 |
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of lymph nodes of chest cavity using an endoscope | 14 | 14 | 13 | 19 | 18 | 14 |
| Diagnostic exam of lung airway using an endoscope | 29 | 17 | – | – | – | – |
| Exam of lung with removal of lung lobe using an endoscope | – | – | – | 19 | 14 | – |
| Initial removal of wedge of lung tissue using an endoscope | – | – | – | – | 13 | 11 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
215 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 9% · Women 59% · Also on Medicaid 17% · Health risk score 1.67. At or below the middle of the specialty; the typical thoracic surgery clinician is at 1.74.
Conditions among them: High blood pressure 74% · Cancer 68% · Coronary heart disease 32% · COPD 32% · Atrial fibrillation 27% · Diabetes 22% · Chronic kidney disease 17% · Depression 15% · Heart failure 14% · Stroke 7%.
The office billed $393,354, Medicare allowed $88,992 and paid $69,647; for 359 services of 34 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 215 | 359 | 75 | 1.67 | $393,354 | $69,647 |
| 2023 | 209 | 383 | 75 | 1.70 | $519,401 | $81,004 |
| 2022 | 209 | 393 | 75 | 1.59 | $602,603 | $95,482 |
| 2021 | 200 | 337 | 74 | 1.62 | $495,030 | $79,369 |
| 2020 | 204 | 421 | 74 | 1.69 | $597,258 | $94,471 |
| 2019 | 209 | 403 | 72 | 1.82 | $492,581 | $85,901 |
| 2018 | 218 | 472 | 73 | 1.90 | $652,532 | $103,118 |
| 2017 | 244 | 567 | 72 | 1.86 | $829,701 | $129,337 |
| 2016 | 244 | 579 | 73 | 2.06 | $834,280 | $127,453 |
| 2015 | 266 | 675 | 73 | 1.87 | $907,810 | $148,928 |
| 2014 | 227 | 599 | 72 | 1.74 | $941,011 | $144,194 |
| 2013 | 155 | 370 | 72 | 1.81 | $506,497 | $86,885 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Exam of lung with removal of lung lobe using an endoscope | 14 | $16,909 | $1,208 |
| Return visit (30+ min) | 113 | $12,303 | $86 |
| New patient visit (60+ min) | 66 | $10,560 | $160 |
| Initial removal of wedge of lung tissue using an endoscope | 13 | $8,435 | $649 |
| Long return visit (40+ min) | 23 | $3,325 | $133 |
| Removal of lymph nodes of chest cavity using an endoscope | 18 | $3,221 | $179 |
| Short return visit (20+ min) | 23 | $1,342 | $58 |
2022: 6 services
| Exam of lung with removal of lung lobe using an endoscope | 19 | $23,080 | $1,215 |
| New patient visit (60+ min) | 70 | $10,974 | $157 |
| Return visit (30+ min) | 95 | $9,702 | $84 |
| Removal of lymph nodes of chest cavity using an endoscope | 19 | $3,460 | $182 |
| Long return visit (40+ min) | 23 | $3,186 | $127 |
| Short return visit (20+ min) | 43 | $2,378 | $54 |
2021: 5 services
| New patient visit (60+ min) | 62 | $10,752 | $173 |
| Return visit (30+ min) | 92 | $9,778 | $85 |
| Long return visit (40+ min) | 22 | $3,042 | $132 |
| Removal of lymph nodes of chest cavity using an endoscope | 13 | $2,419 | $186 |
| Short return visit (20+ min) | 31 | $1,672 | $52 |
2020: 5 services
| New patient visit (60+ min) | 51 | $7,751 | $152 |
| Short return visit (20+ min) | 93 | $4,397 | $41 |
| Return visit (30+ min) | 47 | $3,603 | $68 |
| Removal of lymph nodes of chest cavity using an endoscope | 14 | $2,633 | $188 |
| Diagnostic exam of lung airway using an endoscope | 17 | $1,043 | $61 |
2019: 6 services
| New patient visit (60+ min) | 72 | $10,966 | $152 |
| Short return visit (20+ min) | 100 | $5,582 | $43 |
| Removal of lymph nodes of chest cavity using an endoscope | 14 | $2,575 | $184 |
| Return visit (30+ min) | 28 | $2,081 | $65 |
| Diagnostic exam of lung airway using an endoscope | 29 | $1,675 | $58 |
| Long return visit (40+ min) | 13 | $1,358 | $97 |
2018: 7 services
| Exam of lung with removal of lung lobe using an endoscope | 13 | $15,641 | $1,203 |
| New patient visit (60+ min) | 77 | $11,191 | $145 |
| Initial removal of wedge of lung tissue using an endoscope | 12 | $8,303 | $692 |
| Short return visit (20+ min) | 111 | $5,520 | $41 |
| Removal of lymph nodes of chest cavity using an endoscope | 18 | $3,619 | $181 |
| Diagnostic exam of lung airway using an endoscope | 31 | $2,067 | $59 |
| Return visit (30+ min) | 21 | $1,483 | $67 |
2017: 9 services
| Exam of lung with removal of lung lobe using an endoscope | 13 | $15,087 | $1,161 |
| New patient visit (60+ min) | 86 | $12,165 | $141 |
| Short return visit (20+ min) | 114 | $5,892 | $41 |
| Removal of lymph nodes of chest cavity using an endoscope | 23 | $4,192 | $182 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,526 | $176 |
| Return visit (30+ min) | 41 | $2,901 | $62 |
| Removal of lymph nodes of chest cavity and breast bone | 11 | $1,999 | $182 |
| Diagnostic exam of lung airway using an endoscope | 29 | $1,777 | $61 |
| Long return visit (40+ min) | 11 | $1,008 | $92 |
2016: 12 services
| Exam of lung with removal of lung lobe using an endoscope | 12 | $14,537 | $1,211 |
| New patient visit (60+ min) | 93 | $13,249 | $142 |
| Initial removal of wedge of lung tissue using an endoscope | 15 | $9,158 | $611 |
| Short return visit (20+ min) | 96 | $5,091 | $42 |
| Exam of chest with biopsy of lymph node using an endoscope | 13 | $3,493 | $269 |
| Return visit (30+ min) | 43 | $2,938 | $64 |
| Removal of lymph nodes of chest cavity using an endoscope | 16 | $2,925 | $183 |
| Removal of lymph nodes of chest cavity and breast bone | 16 | $2,917 | $182 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,187 | $121 |
| Diagnostic exam of lung airway using an endoscope | 32 | $2,064 | $64 |
| Long return visit (40+ min) | 13 | $1,214 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $836 | $64 |
2015: 14 services
| New patient visit (60+ min) | 105 | $15,489 | $148 |
| Removal of lobe of lung | 11 | $12,177 | $1,107 |
| Initial removal of wedge of lung tissue using an endoscope | 14 | $9,173 | $655 |
| Short return visit (20+ min) | 94 | $5,392 | $43 |
| Examination of chest cavity below breast bone using an endoscope | 13 | $4,957 | $381 |
| Return visit (30+ min) | 58 | $4,074 | $64 |
| Diagnostic exam of lung airway using an endoscope | 44 | $3,398 | $72 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,050 | $122 |
| Removal of lymph nodes of chest cavity using an endoscope | 16 | $2,932 | $183 |
| Removal of lymph nodes of chest cavity and breast bone | 15 | $2,744 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,991 | $181 |
| Long return visit (40+ min) | 15 | $1,591 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,490 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $487 | $35 |
2014: 10 services
| Exam of lung with removal of lung lobe using an endoscope | 16 | $19,233 | $1,202 |
| New patient visit (60+ min) | 103 | $14,641 | $142 |
| Initial removal of wedge of lung tissue using an endoscope | 16 | $11,269 | $663 |
| Examination of chest cavity below breast bone using an endoscope | 17 | $6,734 | $396 |
| Return visit (30+ min) | 59 | $4,490 | $65 |
| Removal of lymph nodes of chest cavity using an endoscope | 20 | $3,850 | $183 |
| Diagnostic exam of lung airway using an endoscope | 46 | $3,409 | $70 |
| Short return visit (20+ min) | 74 | $3,159 | $39 |
| Removal of lymph nodes of chest cavity and breast bone | 12 | $2,200 | $183 |
| Long return visit (40+ min) | 17 | $1,677 | $99 |
2013: 7 services
| New patient visit (60+ min) | 54 | $7,509 | $139 |
| Examination of chest cavity below breast bone using an endoscope | 11 | $3,818 | $347 |
| Short return visit (20+ min) | 66 | $3,228 | $40 |
| Return visit (30+ min) | 35 | $2,382 | $64 |
| Diagnostic exam of lung airway using an endoscope | 29 | $2,196 | $73 |
| Removal of lymph nodes of chest cavity using an endoscope | 11 | $1,991 | $181 |
| Long return visit (40+ min) | 13 | $1,243 | $96 |
Drugs they prescribed that Part D paid
$2,886
Pharmacies billed $2,886 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 27) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
23 generic and fewer than 11 brand-name prescriptions · $2,886 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 27 | None | 0% (0) | None | $2,886 |
| 2023 | 48 | 18 | 0% (0) | None | $2,314 |
| 2022 | 14 | None | 0% (0) | None | $444 |
| 2020 | 26 | 11 | None | None | $299 |
| 2019 | 21 | 14 | None | None | $2,907 |
| 2018 | 23 | 12 | 0% (0) | None | $183 |
| 2017 | 43 | 26 | None | None | $1,655 |
| 2016 | 68 | 23 | None | 26% | $7,130 |
| 2015 | 147 | 54 | None | 21% | $10,900 |
| 2014 | 157 | 57 | 15% (24) | None | $15,969 |
| 2013 | 80 | 23 | 16% (13) | None | $9,083 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Digoxin | 12 | $382 | $32 |
2022: 1 drug
| Digoxin | 11 | $378 | $34 |
2015: 1 drug
| Amoxicillin-Clavulanate Potass | 12 | $168 | $14 |
2014: 3 drugs
| Hydrocodone-Acetaminophen | 14 | $226 | $16 |
| Amox Tr-Potassium Clavulanate | 11 | $212 | $19 |
| Metoprolol | 13 | $75 | $6 |
Money from drug and device companies
$2,653 in 2025
| 2025 | 2 | 2 | $2,500 | $2,653 |
| 2024 | 4 | 5 | $2,600 | $3,041 |
| 2023 | 4 | 7 | $2,374 | $2,881 |
| 2022 | 3 | 152 | $1,950 | $2,067 |
| 2021 | 1 | 1 | $2,500 | $2,500 |
| 2020 | 3 | 4 | $13,250 | $13,515 |
| 2019 | 4 | 13 | $26,025 | $29,662 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lungpacer Medical USA | Aeropace Neurostimulation Console | $2,500 | 1 payment
|
| Medtronic | Signia | $153 | 1 payment
|
See all 2 published payments
| Lungpacer Medical USA | Consulting · 2025-10-30 | Aeropace Neurostimulation Console | $2,500 |
| Medtronic | Meals · 2025-01-25 | Signia | $153 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,041
| Bard Peripheral Vascular | None | $2,716 | 2 payments
|
| Medtronic | Signia | $162 | 1 payment
|
| Genentech USA | Alecensa | $87 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $76 | 1 payment
|
2023: $2,881
| Bard Peripheral Vascular | None | $1,334 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $1,261 | 3 payments
|
| Medtronic | Signia | $169 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $118 | 1 payment
|
2022: $2,067
| Medela AG | Invia Motion Endure | $1,500 | 1 payment
|
| Medtronic | None | $450 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $117 | 1 payment
|
2021: $2,500
| Bard Peripheral Vascular | None | $2,500 | 1 payment
|
2020: $13,515
| Bard Peripheral Vascular | None | $13,250 | 1 payment
|
| Covidien LP | Endo Gia | $137 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $129 | 1 payment
|
2019: $29,662
| Becton Dickinson and | Cfn Pleurx | $29,250 | 7 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $247 | 3 payments
|
| Covidien LP | Idrive | $136 | 2 payments
|
| Bard Access Systems | None | $29 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Varian Medical Systems, Inc. · Mra With Stanford · 2020 | Their institution | $16,177 |
| Siemens Medical Solutions USA, Inc. · A Phase I Clinical Trial of Lung Volume Reduction of Severe Emphysema By Stereotactic Ablative Radiation Therapy · 2023 | Their institution | $3,000 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619904521
- Licence
- CA G88316California G88316: Current · expires 2027-11-30
- Trained
- Harvard Medical School, 1988 · 38 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- PA 00167523200001
- Taxonomy
- Thoracic surgery (208G00000X); Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2006-06-27
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.